Newsroom | 5379 results

PLYMOUTH MEETING, Pa.--(BUSINESS WIRE)--Harmony Biosciences Holdings, Inc. (Nasdaq: HRMY), today announced the appointment of Glenn Reicin as Chief Financial Officer, effective immediately, supporting Harmony’s continued focus on strategic growth, financial strength, and long‑term value creation. Harmony is also reiterating its 2026 net product revenue guidance of $1.0 to $1.04 billion. Mr. Reicin is a seasoned biopharmaceutical executive with extensive experience across publicly traded and pri...

DUBLIN--(BUSINESS WIRE)--Alkermes plc (Nasdaq: ALKS) today announced the publication of a 56-week post hoc analysis of the effects of LYBALVI® (olanzapine and samidorphan) on negative symptoms in adults living with schizophrenia in the peer-reviewed publication The Journal of Clinical Psychiatry. The analysis—titled “The Efficacy of Olanzapine/Samidorphan on Negative Symptoms: A Post Hoc Analysis of 56-Week Treatment in Patients With Schizophrenia”—found that treatment with LYBALVI was associat...

FRAMINGHAM, Mass.--(BUSINESS WIRE)--Alzheon, Inc., a clinical-stage biopharmaceutical company developing investigational therapies for patients with Alzheimer’s disease (AD) and related neurodegenerative disorders, today announced it will present new clinical, safety, imaging, and biomarker findings, as well as brain edema (ARIA-E) and brain microhemorrhage (ARIA-H) for its lead investigational therapy, valiltramiprosate/ALZ-801, at the American Academy of Neurology (AAN) Annual Meeting in Chic...

DEERFIELD, Ill.--(BUSINESS WIRE)--Baxter International Inc. (NYSE:BAX), a global medtech leader, is highlighting recent additions to its Global Surgical Solutions and Patient Support Systems portfolios, as well as its broad Advanced Surgery portfolio of hemostatic and sealing agents, at the Association of periOperative Registered Nurses (AORN) Global Surgical Conference & Expo, taking place April 11-14, 2026 in New Orleans. New offerings include the AAT XR spine surgical table and the Dynam...

CAMBRIDGE, Mass.--(BUSINESS WIRE)--Quiver Bioscience receives strategic investment from the Porta family to advance its ASO program for Dup15q syndrome....

MOUNTAIN VIEW, Calif.--(BUSINESS WIRE)--NeuroPace, Inc. (Nasdaq: NPCE), a medical device company focused on transforming the lives of people living with epilepsy, today announced that its management team will present at the 25th Annual Needham Virtual Healthcare Conference at 1:30pm ET (10:30am PT) on Tuesday, April 14, 2026. Management will also host investor meetings during the conference. The presentation will be accessible via live webcast here. A webcast replay will be available for thirty...

DUBLIN--(BUSINESS WIRE)--Prothena promoting Ms. Kingston to Chief Strategy Officer and Mr. Isaacs to General Counsel and Corporate Secretary. Mr. Malecek is departing in June....

PORTO, Portugal--(BUSINESS WIRE)--Para acompañar el Día Mundial del Parkinson, Bial, una empresa biofarmacéutica orientada a la innovación y dedicada a neurociencias y enfermedades raras, lanza en el día de hoy “Diálogos con Parkinson”, una campaña educativa y de sensibilización de un año de duración diseñada para ayudar a una comunicación más clara entre personas que viven con Parkinson, sus cuidadores y profesionales de la salud. El comunicado en el idioma original es la versión oficial y aut...

PORTO, Portugal--(BUSINESS WIRE)--Anlässlich des Welt-Parkinson-Tages startet Bial, ein innovatives Biopharmaunternehmen mit Schwerpunkt auf Neurowissenschaften und seltenen Krankheiten, heute „Dialogues with Parkinson’s“ – eine einjährige Informations- und Sensibilisierungskampagne, um die Kommunikation zwischen Parkinson-Betroffenen, ihren Pflegepersonen und medizinischem Fachpersonal zu verbessern. Die in Zusammenarbeit mit Parkinson’s Europe ins Leben gerufene Initiative verbindet wissensch...

PORTO, Portogallo--(BUSINESS WIRE)--In occasione della Giornata Mondiale del Parkinson, Bial, azienda biofarmaceutica basata sull'innovazione e incentrata sulle neuroscienze e le malattie rare, oggi lancia “Dialogues with Parkinson’s”: una campagna di sensibilizzazione e informazione della durata di un anno, ideata per sostenere una più chiara comunicazione tra le persone affette dal morbo di Parkinson, i loro assistenti e i professionisti sanitari. Il testo originale del presente annuncio, red...